The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …

Vaccines induce specific long-term immunological memory against pathogens, preventing
the worsening of diseases. The COVID-19 health emergency has caused more than 6 …

Abstract The World Health Organization stated on 11 March 2020 that a coronavirus illness
had been discovered in Wuhan, China in December 2019. Effective vaccinations are …

The gold-standard method to evaluate a functional antiviral immune response is to titer
neutralizing antibodies (NAbs) against a viral pathogen. This is historically performed using …

Since the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the causative agent of coronavirus disease 2019 (COVID-19) in late 2019, hundreds of …

Neutralizing antibodies (NAbs) can be indicators of collective immunity, vaccine efficacy,
and the longevity of the humoral response. This study aimed to compare reactogenicity and …

The development of COVID-19 vaccines was promptly regulated to ensure the best possible
approach. By January 2022, 75 candidates reached preclinical evaluation in various animal …

Abstract Background Beginning in March 2021, Mexico vaccinated childcare workers with a
single-dose CanSino Biologics (Adv5-nCoV) coronavirus disease 2019 (COVID-19) …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused the largest
pandemic of this century, and all aspects of this virus are being studied. The efforts to …

Additional COVID-19 vaccines that are safe and immunogenic are needed for global
vaccine equity. Here, we developed a recombinant type 5 adenovirus vector encoding for …